{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:43:21Z","timestamp":1792543401866,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR083110"],"award-info":[{"award-number":["R01 AR083110"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jid.2025.05.030","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:10:46Z","timestamp":1749582646000},"page":"3191-3195.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Pyoderma Gangrenosum: A Systematic Review and Meta-Regression Analysis"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6221-2714","authenticated-orcid":false,"given":"Moira","family":"Shea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1314-4508","authenticated-orcid":false,"given":"Elena Paz","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1009-0974","authenticated-orcid":false,"given":"Iksha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7215-8869","authenticated-orcid":false,"given":"Rama Abu","family":"Zanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-8763","authenticated-orcid":false,"given":"Sidharth","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-9269","authenticated-orcid":false,"given":"Alex G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.05.030_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2025.05.030_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.140.7.861","article-title":"Poor prognosis of arthritis-associated pyoderma gangrenosum","volume":"140","author":"Charles","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001888","article-title":"Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades","volume":"7","author":"Crossfield","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.jid.2025.05.030_bib4","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jid.2025.05.030_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum - a guide to diagnosis and management","volume":"19","author":"George","year":"2019","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jid.2025.05.030_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaad.2024.08.038","article-title":"Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and health care utilization: a prospective cohort study","volume":"91","author":"Haddadin","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","article-title":"How many rare diseases are there?","volume":"19","author":"Haendel","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2025.05.030_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40257-018-0356-7","article-title":"Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis","volume":"19","author":"Kridin","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib9","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.dld.2023.04.003","article-title":"The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"55","author":"Park","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jid.2025.05.030_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.abd.2019.06.001","article-title":"Pyoderma gangrenosum: a review with special emphasis on Latin America literature","volume":"94","author":"Rodr\u00edguez-Z\u00fa\u00f1iga","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib11","first-page":"361","article-title":"Pyoderma gangrenosum among patients with inflammatory bowel disease: a descriptive cohort study","volume":"18","author":"Weizman","year":"2014","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.05.030_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangrenosum--a review","volume":"2","author":"Wollina","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2025.05.030_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2019.08.001","article-title":"Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis","volume":"83","author":"Xu","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaad.2021.05.006","article-title":"Prevalence of inflammatory bowel disease in patients with pyoderma gangrenosum: a population-based analysis","volume":"86","author":"Xu","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib15","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1111\/jdv.20457","article-title":"Effects of comorbidities on delayed wound healing in patients with pyoderma gangrenosum","volume":"39","author":"Zhao","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.05.030_bib16","article-title":"The clinical characteristics of patients with pyoderma gangrenosum in a tertiary referral hospital: a retrospective cohort study","author":"Afacan Y\u0131ld\u0131r\u0131m","year":"2023","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.jid.2025.05.030_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients","volume":"8","author":"Al Ghazal","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2025.05.030_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1610-0387.2011.07734.x","article-title":"Investigation of new co-factors in 49 patients with pyoderma gangrenosum","volume":"10","author":"Al Ghazal","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2025.05.030_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum a comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.jid.2025.05.030_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaad.2015.08.009","article-title":"Pyoderma gangrenosum and inflammatory bowel disease: A cross-sectional inpatient socioeconomic study","volume":"73","author":"Brodell","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40257-024-00844-5","article-title":"Autoimmune, autoinflammatory disease and cutaneous malignancy associations with hidradenitis suppurativa: a cross-sectional study","volume":"25","author":"Brydges","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s10620-016-4195-1","article-title":"Extra-gastrointestinal manifestations of inflammatory bowel disease May be less common than previously reported","volume":"61","author":"Card","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jid.2025.05.030_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/iwj.13196","article-title":"Necrotising fasciitis or pyoderma gangrenosum: a fatal dilemma","volume":"16","author":"Demirdover","year":"2019","journal-title":"Int Wound J"},{"key":"10.1016\/j.jid.2025.05.030_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D385M5P6FT","article-title":"Pioderma gangrenoso - Abordagem cl\u00ednica, laboratorial e terap\u00eautica: revis\u00e3o de 28 casos [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases]","volume":"15","author":"Duarte","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jid.2025.05.030_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bjd.16463","article-title":"Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patients","volume":"179","author":"Gillard","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib28","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jid.2025.05.030_bib29","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/iwj.13211","article-title":"Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: a multi-centre study","volume":"16","author":"Haynes","year":"2019","journal-title":"Int Wound J"},{"key":"10.1016\/j.jid.2025.05.030_bib30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/jcm10061311","article-title":"The temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease: a nationwide population-based cohort study","volume":"10","author":"Hung","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jid.2025.05.030_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/1346-8138.13937","article-title":"Pyoderma gangrenosum and underlying diseases in Japanese patients: a regional long-term study","volume":"44","author":"Inoue","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib32","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e278","article-title":"Severe disease activity based on the Paris classification is associated with the development of extraintestinal manifestations in Korean children and adolescents with ulcerative colitis","volume":"36","author":"Jang","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jid.2025.05.030_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1346-8138.15676","article-title":"Various skin manifestations related to inflammatory bowel disease: a nationwide cross-sectional study on the Korean population","volume":"48","author":"Jo","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/iwj.12387","article-title":"Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany","volume":"13","author":"Jockenh\u00f6fer","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.jid.2025.05.030_bib35","first-page":"1023","article-title":"Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum","volume":"14","author":"Jockenh\u00f6fer","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2025.05.030_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/iwj.12463","article-title":"Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012","volume":"13","author":"Jockenh\u00f6fer","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.jid.2025.05.030_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.gastrohep.2020.07.012","volume":"44","author":"Juliao-Ba\u00f1os","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2025.05.030_bib38","first-page":"116","article-title":"Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey","volume":"9","author":"K\u00f6rber","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2025.05.030_bib39","article-title":"Hematological malignancy-associated pyoderma gangrenosum: evaluating the magnitude of the association","volume":"11","author":"Kridin","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.05.030_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamadermatol.2022.5437","article-title":"Association of all-cause and cause-specific mortality risks with pyoderma gangrenosum","volume":"159","author":"Lee","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1743-6109.2006.00131.x","article-title":"Clinical assessment of infection in nonhealing ulcers analyzed by latent class analysis","volume":"14","author":"Lorentzen","year":"2006","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jid.2025.05.030_bib42","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1067\/mjd.2000.104515","article-title":"Parastomal pyoderma gangrenosum: clinical features and management","volume":"42","author":"Lyon","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib43","first-page":"88","article-title":"Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"6","author":"Menachem","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jid.2025.05.030_bib44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/iwj.12939","article-title":"Epidemiology of pyoderma gangrenosum: results from an Italian prospective multicentre study","volume":"15","author":"Monari","year":"2018","journal-title":"Int Wound J"},{"key":"10.1016\/j.jid.2025.05.030_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4103\/0378-6323.45102","article-title":"Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study","volume":"74","author":"Moravvej","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.05.030_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00403-020-02098-7","article-title":"The inpatient burden and comorbidities of pyoderma gangrenosum in adults in the United States","volume":"313","author":"Narla","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.05.030_bib47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00403-021-02189-z","article-title":"The inpatient burden of pyoderma gangrenosum and associated comorbidities in children in the United States","volume":"314","author":"Narla","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.05.030_bib48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ueg2.12094","article-title":"The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: a post hoc analysis of the UNITI studies","volume":"9","author":"Narula","year":"2021","journal-title":"U Eur Gastroenterol J"},{"key":"10.1016\/j.jid.2025.05.030_bib49","first-page":"768","article-title":"Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)","volume":"51","author":"Ozdil","year":"2004","journal-title":"Hepatogastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.jid.2025.05.030_bib50","article-title":"Crohn's disease; analysis of 105 patients","volume":"50","author":"Ozdil","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jid.2025.05.030_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-4632.2011.05451.x","article-title":"Pyoderma gangrenosum--a review of 24 cases observed over 10 years","volume":"52","author":"Pereira","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.crohns.2010.10.006","article-title":"Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998\u20132009","volume":"5","author":"Polcz","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jid.2025.05.030_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.1989.01670130059007","article-title":"Present status of pyoderma gangrenosum. Review of 21 cases","volume":"125","author":"Prystowsky","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaad.2021.07.032","article-title":"The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: a retrospective cohort study of previously hospitalized patients","volume":"87","author":"Ravi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib55","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaad.2022.02.008","article-title":"Clinical characteristics and misdiagnosis of pyoderma gangrenosum of the head and neck: a retrospective study","volume":"87","author":"Reese","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0378-6323.188654","article-title":"Pyoderma gangrenosum: a clinico-epidemiological study","volume":"83","author":"Riyaz","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.05.030_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210436","article-title":"Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study","volume":"14","author":"Roth","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.jid.2025.05.030_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamadermatol.2018.3890","article-title":"Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis","volume":"155","author":"Sanchez","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2025.05.030_bib59","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/jowc.2018.27.Sup1.S4","article-title":"Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases","volume":"27","author":"Sasor","year":"2018","journal-title":"J Wound Care"},{"key":"10.1016\/j.jid.2025.05.030_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.annder.2021.05.004","article-title":"Leg ulcers in childhood: a multicenter study in France","volume":"149","author":"Say","year":"2022","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.05.030_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/pde.12990","article-title":"Pediatric pyoderma gangrenosum: a retrospective review of clinical features, etiologic associations, and treatment","volume":"34","author":"Schoch","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib62","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3776","article-title":"Pyoderma gangrenosum: a retrospective study of clinical charac-teristics, comorbidities, response to treatment and mortality related to prednisone dose","volume":"101","author":"Sch\u00f8sler","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2025.05.030_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00403-021-02278-z","article-title":"Diagnostic work-up and treatment in patients with pyoderma gangrenosum: retrospective analysis of US insurance claims-based data","volume":"315","author":"Shaigany","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.05.030_bib64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archsurg.135.5.564","article-title":"Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management","volume":"135","author":"Sheldon","year":"2000","journal-title":"Arch Surg"},{"key":"10.1016\/j.jid.2025.05.030_bib65","doi-asserted-by":"crossref","DOI":"10.1590\/1806-9282.20230165","article-title":"Prevalence of skin lesions in a sample of Brazilian patients with inflammatory bowel disease","volume":"69","author":"Silveira","year":"2023","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.jid.2025.05.030_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jss.2016.06.045","article-title":"Pediatric pyoderma gangrenosum: is it just big wounds on little adults?","volume":"206","author":"Soleimani","year":"2016","journal-title":"J Surg Res"},{"key":"10.1016\/j.jid.2025.05.030_bib67","first-page":"4","article-title":"Quand poser l\u2019indication d\u2019une biopsie cutan\u00e9e chez un patient porteur d\u2019ulc\u00e8re de jambe ? \u00c9tude r\u00e9trospective sur 143 biopsies cons\u00e9cutives [When to ask for a skin biopsy in a patient with leg ulcer? Retrospective study of 143 consecutive biopsies]","volume":"43","author":"Stansal","year":"2018","journal-title":"J Med Vasc"},{"key":"10.1016\/j.jid.2025.05.030_bib68","first-page":"20","article-title":"Atypical ulcers: wound biopsy results from a university wound pathology service","volume":"58","author":"Tang","year":"2012","journal-title":"Ostomy Wound Manag"},{"key":"10.1016\/j.jid.2025.05.030_bib69","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaad.2019.02.004","article-title":"Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"80","author":"Tannenbaum","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.05.030_bib70","first-page":"505","article-title":"Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis","volume":"55","author":"Tian","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.jid.2025.05.030_bib71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2001-11153","article-title":"Cutaneous manifestations in inflammatory bowel disease","volume":"39","author":"Tromm","year":"2001","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jid.2025.05.030_bib72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000336719","article-title":"Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease","volume":"85","author":"Uchino","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.jid.2025.05.030_bib73","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/ijd.13591","article-title":"Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients","volume":"56","author":"Vacas","year":"2017","journal-title":"Int J Dermatology"},{"key":"10.1016\/j.jid.2025.05.030_bib74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jid.2025.05.030_bib75","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jid.2025.05.030_bib76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jid.2025.05.030_bib77","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546630410031909","article-title":"Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features","volume":"15","author":"Vidal","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.05.030_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/MEG.0000000000001869","article-title":"Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associations","volume":"32","author":"Waljee","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2025.05.030_bib79","article-title":"Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.05.030_bib80","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","volume":"15","author":"Y\u00fcksel","year":"2009","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25005573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25005573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:26:13Z","timestamp":1778473573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25005573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022202X25005573"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.05.030","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Pyoderma Gangrenosum: A Systematic Review and Meta-Regression Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}